X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (232) 232
Publication (18) 18
Book Review (5) 5
Book Chapter (4) 4
Book / eBook (2) 2
Conference Proceeding (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (149) 149
oncology (139) 139
adult (96) 96
male (93) 93
middle aged (92) 92
female (91) 91
aged (81) 81
sarcoma (70) 70
index medicus (67) 67
chemotherapy (59) 59
adolescent (53) 53
treatment outcome (51) 51
cancer (50) 50
care and treatment (38) 38
retrospective studies (36) 36
disease-free survival (35) 35
surgery (35) 35
antineoplastic agents - therapeutic use (34) 34
combined modality therapy (34) 34
sarcoma - drug therapy (34) 34
aged, 80 and over (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
prognosis (29) 29
survival (29) 29
imatinib mesylate (27) 27
doxorubicin (26) 26
medicine & public health (25) 25
survival rate (25) 25
tumors (25) 25
child (24) 24
soft-tissue sarcomas (24) 24
radiotherapy (23) 23
metastasis (22) 22
ifosfamide (21) 21
sarcoma - pathology (21) 21
doxorubicin - administration & dosage (20) 20
research (20) 20
soft tissue sarcoma (20) 20
benzamides (19) 19
follow-up studies (19) 19
soft tissue neoplasms - drug therapy (19) 19
management (18) 18
risk factors (18) 18
young adult (18) 18
sarcoma - mortality (17) 17
antineoplastic agents - administration & dosage (16) 16
antineoplastic agents - adverse effects (16) 16
chemotherapy, adjuvant (16) 16
survival analysis (16) 16
sarcomas (15) 15
therapy (15) 15
abridged index medicus (14) 14
bone neoplasms - drug therapy (14) 14
drug administration schedule (14) 14
health aspects (14) 14
neoplasm recurrence, local (14) 14
neoplasm staging (14) 14
patients (14) 14
sarcoma - therapy (14) 14
solid tumors (14) 14
analysis (13) 13
clinical trials (13) 13
dosage and administration (13) 13
gastrointestinal stromal tumors - drug therapy (13) 13
osteosarcoma (13) 13
osteosarcoma - drug therapy (13) 13
piperazines - therapeutic use (13) 13
prognostic factors (13) 13
pyrimidines - therapeutic use (13) 13
sarcoma - surgery (13) 13
soft-tissue sarcoma (13) 13
child, preschool (12) 12
gastrointestinal neoplasms - drug therapy (12) 12
imatinib (12) 12
patient outcomes (12) 12
prognostic-factors (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
article (11) 11
clinical trials as topic (11) 11
disease progression (11) 11
gastrointestinal stromal tumors (11) 11
kaplan-meier estimate (11) 11
extremity (10) 10
gemcitabine (10) 10
ifosfamide - administration & dosage (10) 10
leiomyosarcoma (10) 10
metastases (10) 10
neoplasm metastasis (10) 10
sarcoma - secondary (10) 10
soft tissue neoplasms - pathology (10) 10
anthracyclines (9) 9
bone (9) 9
bone neoplasms - mortality (9) 9
dacarbazine - administration & dosage (9) 9
development and progression (9) 9
diagnosis (9) 9
drug therapy (9) 9
ewing sarcoma (9) 9
neoplasms. tumors. oncology. including cancer and carcinogens (9) 9
osteosarcoma - pathology (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1995, Hematology/oncology clinics of North America, Volume 9, no. 3-4., 2 v.
Book
2013, MD Anderson cancer care series, ISBN 1461451930
Web Resource
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2011, Volume 67, Issue S1, pp. 1 - 1
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 01/2011, Volume 67, p. 1
  Issue Title: Gastrointestinal Stromal Tumors (GIST) Special Issue 
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 01/2011, Volume 67, Issue S1, pp. 1 - 1
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10028, pp. 1629 - 1637
Journal Article
Cancer, ISSN 0008-543X, 10/2016, Volume 122, Issue 19, pp. 2952 - 2960
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 01/2011, Volume 67, Issue 1, p. S1
Journal Article
Journal Article
Journal Article
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 06/2017, Volume 18, Issue 6, p. 1
Trabectedin and eribulin are two agents that have been recently approved for the treatment of specific soft tissue sarcoma subtypes. They have proved to be a... 
Soft tissue sarcoma | Eribulin | Trabectedin | Leiomyosarcoma | Liposarcoma | 1ST-LINE TREATMENT | MULTICENTER | DOXORUBICIN | INFUSION | COMBINATION | CHEMOTHERAPY | MESYLATE | ONCOLOGY | RANDOMIZED PHASE-II | ECTEINASCIDIN-743 ET-743 | Antimitotic agents | Dosage and administration | Sarcoma | Drug therapy | Antineoplastic agents
Journal Article
Cancer, ISSN 0008-543X, 09/2019
The results of the randomized, phase 3 ET743-SAR-3007 trial demonstrated that trabectedin had a significantly longer progression-free survival (PFS) compared... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2007, Volume 25, Issue 13, pp. 1785 - 1791
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 02/2009, Volume 23, Issue 1, pp. xiii - xiv
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2007, Volume 25, Issue 19, pp. 2755 - 2763
Purpose Gemcitabine as a single agent and the combination of gemcitabine and docetaxel have activity in patients with metastatic soft tissue sarcoma. To... 
TRIAL | RESISTANT | SOLID TUMORS | ONCOLOGY | DOXORUBICIN | ACUTE STROKE | ADAPTIVE DOSE-RESPONSE | EUROPEAN-ORGANIZATION | IFOSFAMIDE | CANCER | CHEMOTHERAPY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.